Investigating the causes and progression of axial spondylitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the onset and progression of axial spondylitis by including newly diagnosed, treatment-naive patients. Participants will be followed for two years, during which clinical data, questionnaires, and biological samples (blood and urine) will be collected. The focus is on understanding the role of prostaglandins and other substances in the disease to improve treatment and potentially prevent its onset. The study seeks to identify biomarkers that could lead to more personalized therapies for axial spondylitis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* newly diagnosed patients with axial spondyloarthritis
* treatment-naive
* 18 years of age or older
* Swedish-speaking
* Able to give informed consent

Exclusion Criteria:

* DMARD treatment,
* ongoing infection
* ongoing malignancy

Where it's running

• Karolinska University Hospital
  Huddinge, Stockholm County, Sweden Recruiting
• Center for Rheumatology Stockholm
  Stockholm, Stockholm County, Sweden Recruiting

Study contacts

• Study coordinator: Per-Johan Jakobsson, MD PhD Professor
• Email: per-johan-jakobsson@ki.se
• Phone: 0725848033

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Surface topography and spine damage in radiographic axial spondyloarthritis

  This study tests whether a radiation-free 3D surface topography method can reflect spine damage and sagittal balance in adults with radiographic axial spondyloarthritis.

  Recruiting Ankara Etlik City Hospital · Ankara, Yenimahalle · NCT07855393

• RENEW: a digital program to help people with axial spondyloarthritis manage energy and symptoms

  A web-based, peer-led program called RENEW is tested to see if people with axial spondyloarthritis can easily use it, like it, and benefit from it in managing fatigue and symptoms.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT07836374

• ExerciseRx app for people with axial spondyloarthritis

  A mobile app called ExerciseRx is tested to see if it helps people with axial spondyloarthritis exercise more regularly and feel better than usual care.

  Recruiting at 2 sites University of Washington · Seattle, Washington and 1 other locations · NCT07642622

• Carotid ultrasound to guide prevention of heart disease in inflammatory rheumatic diseases

  In people with inflammatory rheumatic diseases like RA, PsA, AxSpA, or SLE who are at modest cardiovascular risk, a carotid ultrasound test is used to see if they should start stronger lipid-lowering therapy to prevent heart problems.

  Recruiting at 7 sites Phase 4 Instituto de Investigación Marqués de Valdecilla · Alicante, Alicante and 16 other locations · NCT07611747

• Bimekizumab by IV infusion versus subcutaneous injection for adults with psoriatic arthritis or axial spondyloarthritis

  This trial tests whether bimekizumab given by intravenous (IV) infusion behaves the same in the body as the usual subcutaneous injection in adults with psoriatic arthritis or axial spondyloarthritis.

  Recruiting at 65 sites Phase 1 UCB Pharma · Peoria, Arizona and 64 other locations · NCT07290036

• Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases

  This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.

  Recruiting at 2 sites Phase 4 University of Sao Paulo General Hospital · São Paulo, São Paulo and 1 other locations · NCT07087912

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.